ArticleFrontiers in oncology2024

Insights into uveitis from Brentuximab vedotin in refractory Hodgkin's lymphoma: a case report and brief review.

Mengyuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.